Bangladesh is expected to graduate from the least developed country (LDC) category and become classified as a developing country in the later part of 2026. This transition
will make Bangladesh ineligible for the waiver in relation to the pharmaceutical patents under the Agreement on Trade-Related Aspects of Intellectual Property Rights [...]